Chueh, Ju-Yu
Marosfoi, Miklos G.
Anagnostakou, Vania
Arslanian, Rose A.
Marks, Michael P.
Gounis, Matthew J http://orcid.org/0000-0002-8034-2785
Funding for this research was provided by:
ThrombX Medical (statement of work 1)
Article History
Received: 26 June 2020
Accepted: 7 October 2020
First Online: 11 November 2020
Compliance with Ethical Standards
:
: Chueh: Fee-for-service consulting for Stryker Neurovascular and InNeuroCo Inc.Marosfoi: Fee-for-service consulting for Stryker Neurovascular, ThrombX and InNeuroCo Inc.Anagnostakou: The author declares no conflict of interest.Arslanian: The author declares no conflict of interest.Marks: Founder and shareholder in ThrombX.MJG: Has been a consultant on a fee-per-hour basis for Cerenovus, Imperative Care, Medtronic Neurovascular, Mivi Neurosciences, Phenox, Route 92 Medical, Stryker Neurovascular; holds stock in Imperative Care, InNeuroCo and Neurogami; and has received research support from the National Institutes of Health (NIH), the United States – Israel Binational Science Foundation, Anaconda, Apic Bio, Axovant, Cerenovus, Ceretrieve, Cook Medical, Gentuity, Imperative Care, InNeuroCo, Magneto, Microvention, Medtronic Neurovascular, MIVI Neurosciences, Neuravi, Neurogami, Philips Healthcare, Rapid Medical, Route 92 Medical, Stryker Neurovascular, Syntheon and the Wyss Institute.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Not applicable.
: For this type of study, consent for publication is not required.